18 Jul AABB (Association for the Advancement of Blood & Biotherapies)
Jeff Wren, Vice President, Biotherapies
Oct. 8 | 10:45am | FLW Ballroom F
Bethesda, MD
(Private)
AABB is a global, nonprofit organization dedicated to advancing the quality and safety of cell and gene therapies (CGTs) and other biotherapies. Through internationally recognized standards, accreditation, and education programs, AABB helps ensure that patients receive safe, effective therapies—from cellular starting material collection through advanced therapy handling in pharmacy settings. We collaborate closely with therapy developers, healthcare providers, and competent authorities to foster innovation, support regulatory readiness, and promote trusted partnerships across the CGT ecosystem. AABB’s offerings include accreditation for collection and processing facilities, standards for pharmacy-based handling of advanced therapies, and credentialing programs that help companies build qualified teams and accelerate market readiness. With 6,000+ members, 1,300+ accredited facilities, and a network of engaged stakeholders, AABB provides the infrastructure and community to drive progress and expand access to transformative therapies worldwide.
